HELLS and head and neck squamous cell carcinoma: MIR9-3HG showed a broad correlation with multiple FEGs, such as STMN1, CBS, and HELLS. Previous studies also further supported that MIR9-3HG was a prognosis-related biomarker in HNSCC (Hu et al., 2020; Guo et al., 2021).